Table 1.
Cancer Site | ICD-FT-O |
Study enrollment-2005 with multiple primaries |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Males (7417 per-yrs) | Females (7734 per-yrs) | Total (15151 per-yrs) | |||||||||
O** | SIR | 95% CI | O** | SIR | 95% CI | O** | E** | SIR | 95% CI | ||
All | 52 | 1.2 | 0.91–1.6 | 58 | 1.4 | 1.1–1.9 | 110 | 83 | 1.3 | 1.1–1.6 | |
All except NPC | Exclude 147 | 36 | 0.87 | 0.61–1.2 | 49 | 1.2 | 0.91–1.6 | 85 | 81 | 1.0 | 0.83–1.3 |
Cancers associated with infectious agents | |||||||||||
Oral | 140–149 (except 142, 147) | 4 | 0.97 | 0.26–2.5 | 1 | 2.0 | 0.03–11 | 5 | 4.7 | 1.1 | 0.35–2.5 |
Salivary glands | 142 | 1 | 8.3 | 0.11–46 | 0 | 0 | 0–45 | 1 | 0.2 | 5.0 | 0.07–28 |
Nasopharyngeal | 147 | 16 | 13 | 7.6–22 | 9 | 21 | 9.6–40 | 25 | 1.6 | 15 | 10–23 |
Esophagus | 150 | 1 | 0.70 | 0.01–3.9 | 1 | 6.3 | 0.08–35 | 2 | 1.6 | 1.3 | 0.14–4.6 |
Gastric | 151 | 1 | 0.35 | 0–2.0 | 2 | 1.1 | 0.12–4.0 | 3 | 4.7 | 0.64 | 0.13–1.9 |
Liver & intrahepatic bile ducts | 155 | 9 | 1.1 | 0.51–2.1 | 4 | 1.0 | 0.28–2.6 | 13 | 12 | 1.1 | 0.58–1.9 |
Cervix uteri | 180 | -- | -- | -- | 12 | 1.7 | 0.89–3.0 | 12 | 7 | 1.7 | 0.89–3.0 |
Vulva/vagina | 184 | -- | -- | -- | 1 | 4.0 | 0.05–22 | 1 | 0.25 | 4.0 | 0.05–22 |
Hodgkin’s lymphoma | 201 | 0 | 0 | 0–77 | 1 | 36 | 0.46–198 | 1 | 0.08 | 13 | 0.17–74 |
Non-Hodgkin’s lymphoma | 200, 202 | 0 | 0 | 0–3.9 | 1 | 1.2 | 0.03–6.8 | 1 | 1.8 | 0.57 | 0.01–3.2 |
Infectious + NPC | 32 | 1.71 | 1.2–2.4 | 32 | 2.1 | 1.5–3.0 | 64 | 34 | 1.9 | 1.5–2.4 | |
Infectious − NPC | 16 | 0.91 | 0.52–1.5 | 23 | 1.6 | 1.0–2.4 | 39 | 32 | 1.2 | 0.87–1.7 | |
Cancers not associated with infectious agents * | |||||||||||
Colorectal | 153–154 | 3 | 0.54 | 0.11–1.6 | 2 | 0.39 | 0.04–1.4 | 5 | 11 | 0.47 | 0.15–1.1 |
Respiratory system | 160–165 | 3 | 0.44 | 0.09–1.3 | 4 | 1.1 | 0.29–2.8 | 7 | 11 | 0.66 | 0.27–1.4 |
Trachea, bronchus and lung | 162 | 3 | 0.50 | 0.10–1.5 | 4 | 1.2 | 0.31–3.0 | 7 | 9.4 | 0.74 | 0.30–1.5 |
Breast | 174–175 | 0 | 0 | 0–97 | 8 | 1.2 | 0.52–2.4 | 8 | 6.7 | 1.2 | 0.51–2.4 |
Urinary bladder | 188–189 | 5 | 1.9 | 0.60–4.4 | 4 | 2.1 | 0.56–5.3 | 9 | 4.6 | 2.0 | 0.89–3.7 |
Restricted to individual cancers or grouped cancers with > 5 observed or expected events
O=observed and E=expected